Test Price
2,800 AED✅ Home Collection Available
FLNA Gene Otopaladigital Syndrome Type 2 Genetic Test – Dubai, UAE | 2800 AED
Executive Summary & Core Metrics
- Accuracy Guarantee: 99.9% diagnostic sensitivity via ISO 9001:2015 certified NGS processing (Cert: INT/EGQ/2509DA/3139).
- Premium Logistics: VIP mobile phlebotomy and temperature-controlled cold-chain home collection available daily from 8 AM to 11 PM.
- Clinical Guidance: Complimentary telephonic post-test interpretation session with a DHA-licensed Consultant Medical Genetics specialist.
- Insurance & Billing: Direct verification via WhatsApp +971 54 548 8731 (text accepted).
This test is performed at DNA Labs UAE, a DHA-licensed facility (License No. 1143). All molecular analyses are conducted under stringent ISO-certified protocols with full traceability and clinical validation.
Test Overview & Methodology
Otopaladigital syndrome type 2 (OPD2) is an X-linked dominant disorder caused by pathogenic variants in the FLNA gene. The condition presents with skeletal dysplasia, distinctive craniofacial features, and conductive hearing loss. This advanced Next-Generation Sequencing (NGS) test provides comprehensive analysis of the FLNA coding region and splice sites to confirm the diagnosis, guide multidisciplinary management, and inform family planning decisions.
| Feature | Our FLNA NGS Test | Closest Alternative (Sanger Sequencing) |
|---|---|---|
| Precision | 99.9% diagnostic sensitivity; full gene coverage including all coding exons and flanking intronic regions | ~99% accuracy; limited to pre-selected targeted regions only |
| Method | NGS on Illumina® platform with paired-end reads and comprehensive variant detection (SNVs, indels, CNVs) | Capillary electrophoresis sequencing of defined amplicons |
| Turnaround Time | 3 to 4 Weeks | 4 to 6 Weeks |
Physician Insight & Safety Protocols
"As a Consultant Medical Genetics specialist, I recognize the profound impact that a confirmed genetic diagnosis can have on patient management and family counselling. This NGS-based FLNA gene test delivers the molecular clarity required to guide clinical decisions for Otopaladigital syndrome type 2. Results must always be correlated with complete physical examination findings and imaging studies for optimal patient outcomes."
— Lina Osama Zaki Quteineh, Consultant Medical Genetics, DHA Registration ID: 9294403
Advisory – Medication Continuity
Do not discontinue, adjust, or alter any prescribed medication regimen without prior consultation with your treating physician. Genetic test results are intended to inform clinical management and should never replace direct medical supervision.
Patient Safety – Exclusion Criteria & Red Flags
- Exclusion: The test cannot be performed if the patient is unwilling or unable to provide informed consent; guardian consent is mandatory for minors in accordance with UAE Federal Law.
- Exclusion: Samples exhibiting extreme haemolysis, inadequate DNA yield, or improper storage will be rejected and recollection arranged at no additional charge.
- Emergency Red Flags: Seek immediate ENT and orthopedic evaluation if your child develops acute hearing deterioration, rapid progression of limb deformity, or any respiratory compromise.
- Mandatory: This test serves as a diagnostic aid only; all results must be interpreted and contextualised by a DHA-licensed clinical geneticist or qualified medical specialist.
Patient FAQ & Clinical Guidance
1. What is the FLNA gene test for Otopaladigital syndrome type 2 used for?
Clinical Answer: This test detects pathogenic variants in the FLNA gene to confirm or exclude a diagnosis of Otopaladigital syndrome type 2, enabling accurate clinical management, surveillance planning, and informed family counselling.
2. How is the FLNA genetic test performed?
Clinical Answer: A peripheral blood sample is collected by a trained phlebotomist at your preferred location, then the extracted DNA undergoes comprehensive Next-Generation Sequencing of the FLNA gene in our ISO-certified laboratory facility.
3. What is the turnaround time for results?
Clinical Answer: Results are typically delivered within 3 to 4 weeks from sample receipt, allowing rigorous bioinformatic analysis, variant interpretation, and multi-level clinical review before report release.
UAE Regulatory & Data Privacy Adherence
Data Protection & Confidentiality: All genetic data is processed and stored in full compliance with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. Patient information is encrypted, access-controlled, and never shared without explicit consent.
Clinical Safety & Consent: All diagnostic procedures adhere to the standards outlined in Federal Decree-Law No. 4 of 2016 on Medical Liability, ensuring that informed consent is obtained and that patient rights are fully protected throughout the testing pathway.
DHA Oversight: DNA Labs UAE operates under DHA Facility License Number 1143 and is subject to regular inspection and quality assurance audits by the Dubai Health Authority.
Clinical & Logistical Metadata
| Test Name | FLNA Gene Otopaladigital Syndrome Type 2 Genetic Test (NGS) |
| Price (AED) | 2,800 AED |
| Turnaround Time | 3 to 4 Weeks |
| Sample Type / Matrix | Peripheral whole blood (3–5 mL in EDTA tube); VIP mobile phlebotomy and temperature-controlled cold-chain home collection available daily from 8 AM to 11 PM |
| Methodology Used | Next-Generation Sequencing (NGS) on Illumina® platform with full FLNA gene coverage |
| ICD-10-CM Code | Q87.0 (Congenital malformation syndromes predominantly affecting facial appearance) |
| LOINC Code | 55233-1 (Genetic analysis) |
| DHA Facility License & Laboratory Address | License No. 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE | DNA Labs UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians